Skip to content

Effects of different pressure hyperbaric oxygen therapy on daily living ability and motor function in patients with cerebral hemorrhage

Effect of different pressure hyperbaric oxygen therapy on daily living ability and motor function of patients with cerebral hemorrhage

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025603
Enrollment
Unknown
Registered
2019-09-02
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral hemorrhage

Interventions

control group:HBO of 2.0 ATA on the Basis of Comprehensive Treatment
Experimental group:HBO of 2.5 ATA on the Basis of Comprehensive Treatment

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. It meets the stroke standard set by the 4th National Conference on Cerebrovascular Diseases; 2. Moderate to severe cerebral hemorrhage; 3. The location of bleeding is important, and the clinical symptoms are obvious (such as hemiplegia, aphasia, dysphagia, etc.). Those who are more likely to be disabled; 4. Informed consent of patients and their families.

Exclusion criteria

Exclusion criteria: 1. Those who are in critical condition and have already suffered from cerebral hernia; 2. Patients who are agitated, convulsive and unable to cooperate with oxygen inhalation; 3. Absolute contraindications: if internal bleeding is uncontrolled, with bullae or severe emphysema, pneumothorax is not disposed of; 4. Hypertension, more than 200/110 mmHg; 5. Those with mild symptoms and no sequelae, though not contraindication, do not need to do hyperbaric oxygen.

Design outcomes

Primary

MeasureTime frame
GCS;Fugl-Meyer;Barthel;NIH;

Countries

China

Contacts

Public ContactPan Sibing

Shengjing Hospital of China Medical University

289372745@qq.com+86 18940252147

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026